Please login to the form below

Not currently logged in
Email:
Password:

FDA`

This page shows the latest FDA` news and features for those working in and with pharma, biotech and healthcare.

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug. Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig. ... Teva has secured US approval for migraine drug Ajovy, a key part of new chief execeutive Kåre Schultz's turnaround plan for the

Latest news

More from news
Approximately 31 fully matching, plus 861 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Opdivo after standard treatment of early-stage lung cancer can reduce recurrences and help patients live longer by killing tumour cells remaining after surgery and standard chemotherapy. ... article – but, as recent experience with Incyte and Nektar

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    2004. Fifteen years on, the company’s lead product candidate, Lynovex, for the treatment of acute pulmonary exacerbations in Cystic Fibrosis, was recently granted FDA Fast Track Designation. ... I am focused most on how to make the average person

  • Significant figures Significant figures

    US regulators at the FDA have recognised the treatment’s potential, handing it breakthrough and fast-track status. ... Offering an on-label treatment. The current standard of care for treating patients with NTM lung disease consists of a triple

  • The good, the bad and the ugly The good, the bad and the ugly

    The main drivers of revenue for Roche are well-established, standard-of-care blockbuster oncology drugs including Rituxan, Herceptin and Avastin. ... The data this article was based on is available in full online: pmlive.com/top_pharma_list.

  • The gold standard of scientific evidence The gold standard of scientific evidence

    The gold standard of scientific evidence. Will randomised controlled trials become a thing of the past? ... The FDA uses RWE to monitor drug safety as part of the Sentinel project.

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 42 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 37 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics